PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2017.46020185041164-1174Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib TreatmentJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kuo-Hsuan Hsu, Yen-Hsiang Huang, Kang-Yi Su, Sung-Liang Yu, Gee-Chen Changhttp://e-crt.org/upload/pdf/crt-2017-460.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2017.460, http://e-crt.org/upload/pdf/crt-2017-460.pdf
The Lancet Respiratory Medicine10.1016/s2213-2600(17)30085-1201754251Osimertinib improves progression-free survival in NSCLCSheila Pinionhttps://api.elsevier.com/content/article/PII:S2213260017300851?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S2213260017300851?httpAccept=text/xml
The Lancet Oncology10.1016/s1470-2045(17)30893-82018191e10Osimertinib improves progression-free survival in NSCLCRobert Stirrupshttps://api.elsevier.com/content/article/PII:S1470204517308938?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1470204517308938?httpAccept=text/plain
Cancer Treatment Reviews10.1016/j.ctrv.2014.11.004201541277-93A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemiaPiotr Ladyzynski, Maria Molik, Piotr Foltynskihttps://api.elsevier.com/content/article/PII:S030573721400190X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S030573721400190X?httpAccept=text/plain
Cancer Treatment Reviews10.1016/j.ctrv.2011.01.0022011377495-504Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpointSara A. Hurvitzhttps://api.elsevier.com/content/article/PII:S0305737211000041?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737211000041?httpAccept=text/plain
Neoplasia10.1593/neo.06838200793181-IN2Low Expression of ARHI Is Associated with Shorter Progression-Free Survival in Pancreatic Endocrine TumorsIrene Dalai, Edoardo Missiaglia, Stefano Barbi, Giovanni Butturini, Claudio Doglioni, Massimo Falconi, Aldo Scarpahttps://api.elsevier.com/content/article/PII:S1476558607800480?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1476558607800480?httpAccept=text/plain
Reactions Weekly10.1007/s40278-018-53263-6201817241285-285Osimertinibhttp://link.springer.com/content/pdf/10.1007/s40278-018-53263-6.pdf, http://link.springer.com/article/10.1007/s40278-018-53263-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-53263-6.pdf
Hematological Oncology10.1002/hon.2438_77201735212-213PROGRESSION-FREE SURVIVAL FOLLOWING LENALIDOMIDE-BASED TREATMENT IS SIGNIFICANTLY LONGER IN EXTRAGASTRIC THAN IN GASTRIC MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA (MALT LYMPHOMA)B. Kiesewetter, M.E. Mayerhoefer, W. Dolak, J. Lukas, I. Simonitsch-Klupp, M. Radererhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2438_77, http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2438_77/fullpdf
Nature Clinical Practice Urology10.1038/ncpuro0844200748405-405Adjuvant docetaxel following radical prostatectomy improves progression-free survivalhttp://www.nature.com/articles/ncpuro0844.pdf, http://www.nature.com/articles/ncpuro0844, http://www.nature.com/doifinder/10.1038/ncpuro0844, http://www.nature.com/articles/ncpuro0844.pdf
Oncology Research and Treatment10.1159/000375392201538388-94Relationship between Treatment Effects on Progression-Free Survival and Overall Survival in Multiple Myeloma: A Systematic Review and Meta-Analysis of Published Clinical Trial DataShannon Cartier, Bin Zhang, Virginia M. Rosen, Victoria Zarotsky, J. Blake Bartlett, Pralay Mukhopadhyay, Samuel Wagner, Catherine Davishttps://www.karger.com/Article/Pdf/375392, https://www.karger.com/Article/Pdf/375392